Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

Market Cap	10.04B +21.2%
Revenue (ttm)	5.20B +3.3%
Net Income	207.76M +38.9%
EPS	0.27 +35.0%
Shares Out	760.85M
PE Ratio	48.30
Forward PE	26.65
Dividend	0.06 (0.45%)
Ex-Dividend Date	Sep 25, 2025

Volume	7,676,378
Average Volume	7,251,428
Open	13.14
Previous Close	13.19
Day's Range	13.08 - 13.32
52-Week Range	11.48 - 20.37
Beta	0.34
RSI	34.83
Earnings Date	Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 5,417
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300171

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.